Contact Us | Print Page | Report Abuse | Sign In | Join
Endocannabinoid Medicine CME

Learning systems for physicians interested in gaining accredited certification in endocannabinoid medicine. 

In keeping with our mission to provide the most up-to-date education on edocannabinoid science, the Endocannabinoid Learning System includes 4 modules that cover the following topics:

 
  • Level 100: Understanding Cannabinoids, the ECS, and Their Therapeutic Impact
  • Level 200: All About Cannabinoids
  • Level 201: The ECS and Therapeutic Targets
  • Level 202: Cannabinoids in Clinical Practice (Available May 2020) 

Successful completion of all four levels confers a total of twelve 12.0 AMA PRA Category 1 CreditsTM.  Licensed Nurses and Pharmacists may apply to their boards for recognition of AMA PRA Category 1 CreditsTM.

  

When registering, please use the email address that MSNJ has on file to receive the discounted price.

Not a member?: Become a Member | Purchase Full Price (Non-Member)


OBJECTIVES:
  1. Describe the therapeutic potential of the ECS and conditions that may be treated with cannabinoids
  2. Understand the receptor targets, signaling pathways of endocannabinoids, phytocannabinoids, and approved cannabinoid prescription therapies
  3. Apply practical tips on dosing and titration by condition, including potential adverse reactions and drug-drug interactions. 

ACCREDITATION AND CREDIT DESIGNATION STATEMENT

Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Voxmedia LLC designates this enduring material for a maximum of 12 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.